Target Name: KRT18P49
NCBI ID: G392516
Other Name(s): keratin 18 pseudogene 49 | Keratin 18 pseudogene 49

KRT18P49: A Potential Drug Target and Biomarker

Keratin is a protein that is found in the hair, nails, and skin. It is an essential component of these tissues and plays a crucial role in their growth and development. One of the proteins that is known to be involved in the formation of keratin is KRT18P49. KRT18P49 is a pseudogene that encodes a protein that is similar to the keratin protein found in the hair, nails, and skin.

Recent studies have suggested that KRT18P49 may have potential as a drug target or biomarker. This protein has been shown to play a role in the development and progression of various diseases, including cancer, skin diseases, and autoimmune disorders.

One of the potential reasons for the potential drug target status of KRT18P49 is its involvement in the development of cancer. Studies have shown that KRT18P49 is often overexpressed in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that targeting this protein may be an effective way to treat these cancers.

Another potential mechanism by which KRT18P49 may be involved in the development of cancer is its role in cell signaling. KRT18P49 has been shown to play a role in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway is involved in the development and maintenance of tissues and is a known risk factor for various diseases, including cancer. By targeting KRT18P49, researchers may be able to disrupt these signaling pathways and prevent the development of cancer.

In addition to its potential role in cancer development, KRT18P49 has also been shown to be involved in the development of skin diseases. Studies have shown that KRT18P49 is overexpressed in various skin diseases, including eczema, psoriasis, and dermatitis. This suggests that targeting this protein may be an effective way to treat these diseases.

Another potential reason for the potential biomarker status of KRT18P49 is its involvement in autoimmune disorders. KRT18P49 has been shown to play a role in the development of autoimmune disorders, including rheumatoid arthritis and systemic lupus erythematosus. This suggests that targeting this protein may be an effective way to treat these disorders.

Overall, KRT18P49 is a protein that has been shown to play a role in the development and progression of various diseases. Its potential as a drug target or biomarker makes it an attractive target for further research. As future studies continue to investigate the role of KRT18P49, researchers may be able to develop new treatments for a variety of diseases.

Protein Name: Keratin 18 Pseudogene 49

More Common Targets

KRT18P5 | KRT18P50 | KRT18P51 | KRT18P55 | KRT18P59 | KRT18P6 | KRT18P62 | KRT19 | KRT19P2 | KRT19P3 | KRT2 | KRT20 | KRT222 | KRT23 | KRT24 | KRT25 | KRT26 | KRT27 | KRT28 | KRT3 | KRT31 | KRT32 | KRT33A | KRT33B | KRT34 | KRT35 | KRT36 | KRT37 | KRT38 | KRT39 | KRT4 | KRT40 | KRT42P | KRT5 | KRT6A | KRT6B | KRT6C | KRT7 | KRT7-AS | KRT71 | KRT72 | KRT73 | KRT73-AS1 | KRT74 | KRT75 | KRT76 | KRT77 | KRT78 | KRT79 | KRT8 | KRT80 | KRT81 | KRT82 | KRT83 | KRT84 | KRT85 | KRT86 | KRT87P | KRT89P | KRT8P10 | KRT8P11 | KRT8P12 | KRT8P14 | KRT8P16 | KRT8P17 | KRT8P18 | KRT8P22 | KRT8P23 | KRT8P25 | KRT8P26 | KRT8P29 | KRT8P3 | KRT8P33 | KRT8P36 | KRT8P37 | KRT8P39 | KRT8P41 | KRT8P44 | KRT8P45 | KRT8P46 | KRT8P47 | KRT8P48 | KRT8P49 | KRT8P5 | KRT8P7 | KRT8P8 | KRT8P9 | KRT9 | KRT90P | KRTAP1-1 | KRTAP1-3 | KRTAP1-4 | KRTAP1-5 | KRTAP10-1 | KRTAP10-10 | KRTAP10-11 | KRTAP10-12 | KRTAP10-2 | KRTAP10-3 | KRTAP10-4